Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.3258
Delayed Data
As of Feb 16
 +0.0047 / +1.45%
Today’s Change
0.14
Today|||52-Week Range
0.45
+38.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-30.7M-12.6M-10.3M-23.3M
 
 
 
 
 
Depreciation54.0K56.0K44.0K41.0K
 
 
 
 
 
Total Other Cash Flow6.0M469.0K1.1M10.1M
 
 
 
 
 
Funds From Operations-24.7M-12.1M-9.1M-13.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-10.6M188.0K-5.4M-7.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.1M-12.3M-3.7M-5.7M
 
 
 
 
 
 
InvestingCapital Expenditures-169.0K0.00-9.0K-5.0K
 
 
 
 
Fixed Asset Disposal--218.0K2.0K--
 
 
 
Other Investing - Sources-550.0K0.000.00220.0K
 
 
 
Net Cash Flow Investing-719.0K218.0K-7.0K-5.0K
 
 
 
 
 
 
FinancingShort Term Borrowings-------699.0K
 
 
Long Term Borrowings5.7M3.0M2.5M891.0K
 
 
 
 
 
Long Term Debt Reduction0.00-1.7M-1.5M0.00
 
 
 
Net Proceeds Stock Sale11.8M6.7M982.0K7.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing17.5M8.0M3.9M8.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.2M-622.0K-2.4M-1.3M
 
 
 
 
 
 
Net Change In Cash2.7M-4.0M151.0K2.4M